Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio Bria

Showing results (71-80 of 416) with videos related to

Pageof 42
Sort By:
Critical Reviews in Oncology/Hematology|March 18, 2018
Efficacy of neurokinin-1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based chemotherapy: A systematic review and meta-analysisMassimo Di Maio, Chiara Baratelli, Paolo Bironzo, et al.
Journal of Clinical Medicine|June 2, 2021
Oncological Frontiers in the Treatment of Malignant Pleural MesotheliomaEmanuele Vita, Alessio Stefani, Mariantonietta Di Salvatore, et al.
Future Oncology (London, England)|January 16, 2016
Serial 18F-choline-PET imaging in patients receiving enzalutamide for metastatic castration-resistant prostate cancer: response assessment and imaging biomarkersFrancesca Maines, Orazio Caffo, Davide Donner, et al.
Experimental and Molecular Pathology|February 27, 2017
Pulmonary adenocarcinoma with enteric differentiation: Dissecting oncogenic genes alterations with DNA sequencing and FISH analysisAlessia Nottegar, Fabrizio Tabbò, Claudio Luchini, et al.
Expert Review of Anticancer Therapy|June 16, 2024
The incidence and relative risk of major adverse cardiovascular events and hypertension in patients treated with immune checkpoint inhibitors plus tyrosine-kinase inhibitors for solid tumors: a systemic review and meta-analysisChiara Ciccarese, Annunziato Anghelone, Alessio Stefani, et al.
Cancers|April 12, 2022
Prognostic Factors in Patients with Breast Cancer Liver Metastases Undergoing Liver Resection: Systematic Review and Meta-AnalysisFederica Galiandro, Salvatore Agnes, Giovanni Moschetta, et al.
Anti-Cancer Drugs|September 1, 2007
Weekly epirubicin and paclitaxel with granulocyte colony-stimulating factor support in previously untreated metastatic breast cancer patients: a phase II studyCecilia Nisticò, Emilio Bria, Federica Cuppone, et al.
Seminars in Oncology|January 23, 2019
Second-line therapy for metastatic urothelial carcinoma: Defining the best treatment option among immunotherapy, chemotherapy, and antiangiogenic targeted therapies. A systematic review and meta-analysisChiara Ciccarese, Roberto Iacovelli, Emilio Bria, et al.
Lung Cancer (Amsterdam, Netherlands)|March 5, 2013
Delivery optimization of erlotinib according to toxicity: may clinical practice go beyond research?Antonio Passaro, Morena Fasano, Emilio Bria, et al.
Expert Review of Anticancer Therapy|December 21, 2017
The development of PARP as a successful target for cancer therapyRoberto Ferrara, Francesca Simionato, Chiara Ciccarese, et al.
Pageof 42

Showing results (71-80 of 416) with videos related to

Sort By:
Pageof 42
Critical Reviews in Oncology/Hematology|March 18, 2018
Efficacy of neurokinin-1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based chemotherapy: A systematic review and meta-analysisMassimo Di Maio, Chiara Baratelli, Paolo Bironzo, et al.
Journal of Clinical Medicine|June 2, 2021
Oncological Frontiers in the Treatment of Malignant Pleural MesotheliomaEmanuele Vita, Alessio Stefani, Mariantonietta Di Salvatore, et al.
Future Oncology (London, England)|January 16, 2016
Serial 18F-choline-PET imaging in patients receiving enzalutamide for metastatic castration-resistant prostate cancer: response assessment and imaging biomarkersFrancesca Maines, Orazio Caffo, Davide Donner, et al.
Experimental and Molecular Pathology|February 27, 2017
Pulmonary adenocarcinoma with enteric differentiation: Dissecting oncogenic genes alterations with DNA sequencing and FISH analysisAlessia Nottegar, Fabrizio Tabbò, Claudio Luchini, et al.
Expert Review of Anticancer Therapy|June 16, 2024
The incidence and relative risk of major adverse cardiovascular events and hypertension in patients treated with immune checkpoint inhibitors plus tyrosine-kinase inhibitors for solid tumors: a systemic review and meta-analysisChiara Ciccarese, Annunziato Anghelone, Alessio Stefani, et al.
Cancers|April 12, 2022
Prognostic Factors in Patients with Breast Cancer Liver Metastases Undergoing Liver Resection: Systematic Review and Meta-AnalysisFederica Galiandro, Salvatore Agnes, Giovanni Moschetta, et al.
Anti-Cancer Drugs|September 1, 2007
Weekly epirubicin and paclitaxel with granulocyte colony-stimulating factor support in previously untreated metastatic breast cancer patients: a phase II studyCecilia Nisticò, Emilio Bria, Federica Cuppone, et al.
Seminars in Oncology|January 23, 2019
Second-line therapy for metastatic urothelial carcinoma: Defining the best treatment option among immunotherapy, chemotherapy, and antiangiogenic targeted therapies. A systematic review and meta-analysisChiara Ciccarese, Roberto Iacovelli, Emilio Bria, et al.
Lung Cancer (Amsterdam, Netherlands)|March 5, 2013
Delivery optimization of erlotinib according to toxicity: may clinical practice go beyond research?Antonio Passaro, Morena Fasano, Emilio Bria, et al.
Expert Review of Anticancer Therapy|December 21, 2017
The development of PARP as a successful target for cancer therapyRoberto Ferrara, Francesca Simionato, Chiara Ciccarese, et al.
Pageof 42